Recentering Parkinson's Disease Trials On Patients

Taking part in a clinical trial is a big decision for anyone – but especially for patients with Parkinson’s disease (PD). Their disease symptoms can make the demands of participation extraordinarily challenging physically, mentally, and emotionally. At the same time, Sponsors naturally want to investigate a wide range of endpoints – a research objective that ultimately makes trials even more burdensome for patients. Clinical trials in PD should be designed carefully and compassionately, with an understanding of, and respect for, patients’ limitations and potential disabilities. By deploying the latest innovations in technology, Sponsors can achieve two goals simultaneously:

1) They can make their trials more patient centric – which boosts recruitment and improves retention

2) They can gain efficiencies and improve data quality